key: cord-0764723-4agi5s9z
authors: Jalali, Valentin al; Scherzer, Sabine; Zeitlinger, Markus
title: Improved immunogenicity against SARS-CoV-2 in a solid organ transplant recipient by switching vaccines
date: 2021-06-27
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2021.06.022
sha: d977dff8aa45a28aa0e4687cc4b7b3ee29740bec
doc_id: 764723
cord_uid: 4agi5s9z

nan

This lack of immunogenicity seems to be most pronounced for individuals taken anti-41 metabolite maintenance immunosuppression. [1, 2] 

Antibody Response to 2-Dose SARS-CoV-2 mRNA

Antibody response to SARS-CoV-2 mRNA vaccine 89 among kidney transplant recipients: a prospective cohort study

Mix-and-match COVID vaccines trigger potent immune response

COVID-19 vaccination: initial reactogenicity data

What level of neutralising antibody protects from 97 COVID-19?